MLF数字营销平台

Home >Medicine & equipment >medicine

还原型谷胱甘肽

Price
Negotiable
Unit
KG
Product number
201711220821499236
Place of Origin
中国 - 山东 - 淄博
  • Product introduction
  • Function:0
    Theory:0
    Application Area:0
    Product Characteristics:0

    【产品名称】还原型谷胱甘肽

    【分子式】C10H17N3O6S

    【分子量】307.32

    【CAS号】70-18-8

    【外观】白色结晶性粉末

     

     
    图片关键词
    图片关键词
     
     
    图片关键词
     
    CAS NO:70-18-8
    分子式:C10H17N3O6S
    分子量:307.32
    外观:白色结晶性粉末
    含量:98.0%-101.0%
    质量规格:JP,EP,USP   企业标准(营养保健规格)
    包装规格:5KG/DRUM,25KG/DRUM
    储存:遮光,密封保存
     
    图片关键词

    ● 氧化型谷胱甘肽
    CAS NO:27025-41-8
    ● S-乙酰-L-谷胱甘肽
    ● 高密度谷胱甘肽
    ● 谷胱甘肽钠盐
    ● 谷胱甘肽酵母提取物:8%,15%,50%
    ● 谷胱甘肽酵母细胞壁
     
    图片关键词

    广泛用于药品,营养保健品,健康功能食品,食品补充剂,美白美容产品,化妆品等等。常用剂型有冻干粉针、片剂、胶囊剂、滴眼液等。
     
    日常营养保健、美白和膳食补充剂
    ● 抗衰老,抗氧化,保持皮肤活力和光泽。(冻干粉针,片剂,胶囊)
    ● 美白皮肤,一直黑色素生成。(片剂,胶囊)
    ● 提高免疫力,增强体内免疫细胞功能,有效防止病毒入侵。(片剂,胶囊)
     
    药物治疗和预防
    ● 保护肝脏,预防和治疗肝脏类疾病。(冻干粉针,片剂,胶囊)
    ● 体内解毒,药物和其他类中毒辅助治疗,促进毒素排出。(冻干粉针,片剂,胶囊,口服液)
    ● 预防和治疗眼类科疾病(滴眼液)
    ● 辅助治疗糖尿病
  • Company Name
    Shandong Jincheng Pharmaceutical Group Co., Ltd.
    Place of Origin
    中国 - 山东 - 淄博

      Shandong Jincheng Pharmaceutical Group Co., Ltd.  (Hereafter named as”JINCHENG PHARM”, Stock code: 300233) was established in 2004 and successful launched in Shenzhen GEM Board on June, 2011. The company is honored as National High-New Technology Enterprise. It has three whole owned subsidiary companies—Shandong Jincheng Kerui Chemical Co.,Ltd., Shandong Huihai Pharmaceutical and Chemical Co.,Ltd. ,Shandong Jincheng Zhonghua Bio-Pharmaceutical Co.,Ltd. and four production bases.The company is dedicated to research and development, production and sales for III、IV Cephalosporin intermediates. In this field, the company has great advantage and established Post-Doctoral Scientific Research station and Enterprise Technical Center of Shandong Province. The company is one of the main suppliers who own obvious competitive advantage for cephalosporin intermediates in the world market. Moreover, the company has formed the High-New technical products chain from basic chemicals to pharmaceutical intermediates and  extend to special APIs and biopharmaceuticals through actively practices the development pattern of “Change the development mode, Adjust the structure”, improve the independent innovation ability and adjusts and optimize the industrial structure.

Send your message to us: